Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Feb 15, 2019; 11(2): 91-101
Published online Feb 15, 2019. doi: 10.4251/wjgo.v11.i2.91
Published online Feb 15, 2019. doi: 10.4251/wjgo.v11.i2.91
Figure 1 LINC02532 was upregulated in gastric cancer and associated with poor prognosis.
A: Expression levels of LINC02532 in gastric cancer (GC) and normal tissue based on the data from the Cancer Genome Atlas database; B: Kaplan-Meier survival analysis showed that patients with high LINC02532 expression had a poorer prognosis than those with low expression; C: Compared with GES-1, LINC02532 was significantly upregulated in four GC cell lines; D: LINC02532 was upregulated in 52 GC tissues. Expression level data are presented as mean ± SE. aP < 0.05 was considered statistically significant. GC: Gastric cancer; TCGA: The Cancer Genome Atlas; GES-1: Gastric epithelium cell line.
- Citation: Zhang C, Ma MH, Liang Y, Wu KZ, Dai DQ. Novel long non-coding RNA LINC02532 promotes gastric cancer cell proliferation, migration, and invasion in vitro. World J Gastrointest Oncol 2019; 11(2): 91-101
- URL: https://www.wjgnet.com/1948-5204/full/v11/i2/91.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i2.91